Zirvegen Biotechnology is a research and development focused biotechnology company established to develop innovative solutions in the fields of animal health and biotechnology. The company focuses on developing diagnostic technologies that enable the rapid and reliable detection of viral and infectious diseases, particularly those affecting cats and dogs. Zirvegen’s core field of work is the development of Lateral Flow Assay (LFIA) based rapid diagnostic kits and biotechnology-driven diagnostic platforms. Operating within Teknopark Ankara, Zirvegen Biotechnology aims to contribute to the development of domestic biotechnology technologies in Türkiye through state-supported R&D projects and academic collaborations. The company aims not only to produce solutions for current needs but also to build a research infrastructure that will enable the development of the biotechnology technologies of the future. In this direction, it adopts a working culture that supports young researchers, encourages multidisciplinary collaboration, and places innovation at its core. Zirvegen Biotechnology’s long-term goal is to become a strong R&D and technology company that brings biotechnology products developed in Türkiye to international markets.